Crucially, the restoration of hnRNPC expression effectively reversed the anti-cancer effects observed upon INTS13 silencing, highlighting hnRNPC as a key mediator in the INTS13-driven oncogenic pathway. The gene discussed is HNRNPC; the disease is cancer.